Zedcor Q2 2025 Earnings: Revenue Up 84%, Net Income Down 67%

Zedcor's Q2 2025 earnings show revenue up 84% to CA$13.5m, but net income down 67% to CA$460.0k. Profit margin dropped to 3.4% from 19% in Q2 2024. EPS declined to CA$0.004 from CA$0.017 in Q2 2024. The company's share price remains unchanged.

Zedcor Inc. (TSX: ZDC) reported its Q2 2025 earnings, showcasing a significant increase in revenue but a decline in net income and profit margins. The company's revenue surged by 84% to CA$13.5 million, a notable improvement over the previous year's CA$7.3 million. However, net income dropped by 67% to CA$460.0k, compared to CA$1.3 million in the same period last year.

The company's profit margin also took a hit, declining to 3.4% from 19% in Q2 2024. This was largely due to increased expenses, which may have been driven by operational costs and investments in growth initiatives. The EPS (Earnings Per Share) declined to CA$0.004 from CA$0.017 in Q2 2024, reflecting the company's reduced profitability.

Despite the mixed financial performance, Zedcor's share price remained unchanged, suggesting that investors are taking a cautious approach to the company's earnings. The company's management has not provided specific details on the reasons behind the decline in net income and profit margins, but it is likely that operational expenses and investment costs played a significant role.

Overall, while Zedcor's revenue growth is encouraging, the company will need to address the declining profitability and profit margins to regain investor confidence and maintain its financial health.

References:
[1] https://www.morningstar.com/news/business-wire/20250814153416/well-health-reports-record-revenue-adjusted-ebitda-and-adjusted-net-profit-in-q2-2025-upgrades-guidance-and-delivers-first-ever-quarter-with-more-than-1-million-patient-visits-in-canada